Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atopic dermatitis management with tacrolimus ointment (Protopic).

A Kapp1, B R Allen, S Reitamo

  • 1Department of Dermatology and Allergology, Hannover Medical University, Hannover, Germany. Kapp.Alexander@MH-Hannover.de

The Journal of Dermatological Treatment
|October 3, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

Allergy·2026
Same author

A rare case of neuro- and otosyphilis in secondary syphilis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Langerhans cell histiocytosis mimicking prurigo nodularis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Neurological disorders are associated with bullous pemphigoid.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

[Gender aspects in angioedema].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2019
Same author

Position statement: topical calcineurin inhibitors in atopic dermatitis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same journal

Active surveillance for basal cell carcinoma: experiences of patients and proxies.

The Journal of dermatological treatment·2026
Same journal

Severe cutaneous adverse reactions associated with systemic antibiotics in acne vulgaris: a systematic review.

The Journal of dermatological treatment·2026
Same journal

Intralesional human papillomavirus vaccination for cutaneous verrucae: a systematic review and meta-analysis of therapeutic efficacy.

The Journal of dermatological treatment·2026
Same journal

JAK inhibitor-associated acne: a mechanistic paradox with important clinical implications.

The Journal of dermatological treatment·2026
Same journal

Efficacy of vunakizumab in patients with moderate-to-severe plaque psoriasis across diverse disease features: a <i>post hoc</i> analysis of a phase-III trial.

The Journal of dermatological treatment·2026
Same journal

Predictors of optimal disease control in atopic dermatitis with abrocitinib: a real-world study.

The Journal of dermatological treatment·2026
See all related articles

Tacrolimus ointment, a new non-steroidal treatment for atopic dermatitis, offers rapid and sustained symptom control. This topical immunomodulator is well-tolerated, providing an effective alternative to corticosteroids.

Area of Science:

  • Dermatology
  • Immunology

Background:

  • Atopic dermatitis is a chronic inflammatory skin condition.
  • Conventional treatments include topical corticosteroids, which have potential side effects.
  • There is a need for alternative, non-steroidal topical therapies.

Purpose of the Study:

  • To evaluate the efficacy and safety of tacrolimus ointment for atopic dermatitis.
  • To assess tacrolimus ointment as a novel non-steroidal immunomodulator.

Main Methods:

  • Extensive clinical development program involving over 16,000 patients.
  • Vehicle-controlled studies, comparative studies (short- and long-term), and long-term safety studies.
  • Investigated tacrolimus 0.1% and 0.03% ointment in adults and children (≥24 months).

Related Experiment Videos

Main Results:

  • Tacrolimus monotherapy demonstrated rapid efficacy, with clinical improvements within three days.
  • Progressive and sustained efficacy was observed during long-term treatment.
  • No major safety concerns were reported; adverse events were mild, moderate, and transient (application-site burning, pruritus, erythema).

Conclusions:

  • Tacrolimus ointment is effective in treating atopic dermatitis signs and symptoms.
  • It reduces disease flares and offers potential for long-term disease control.
  • Tacrolimus ointment is a well-tolerated alternative to topical corticosteroids in dermatology.